BioXtek envisions medical therapeutics derived from human placental tissues and their components to be processed into pharmaceutical grade therapies to regenerate sick or injured tissues at the cellular level.

Their Mission is to bring a new biologic paradigm to allopathic medical treatments for improved patient outcomes in a wide spectrum of medical and surgical pathologies, without side effects or adverse events, and high levels of patient successful outcomes.